Skip to content
March 29, 2024

Equity.Guru

Investment information for the new generation

Search

CYBN.NEO

Cybin (CYBN.NEO), a Canadian-based biopharmaceutical company working to transform psychedelics into therapeutics, announced today that it had received approval from an independent ethics committee in the Netherlands to commence…
Cybin (CYBN.NE) announced today that it has closed its previously announced overnight marketed offering including the exercise in full of the over-allotment option granted to the Underwriters. “Investor demand…
Back in January of this year, we told you about a psychedelics company that was going to come at that sector like many had talked about, but few had…
“The truth is that everyone is bored, and devotes himself to cultivating habits.” –  Albert Camus, The Plague E-commerce For decades companies have invested billions trying to understand consumer behavior,…
Shamans among the machines In his 1999 lecture titled ‘Shamans Among the Machines’ Terence McKenna pointed out that “as far as people and machines are concerned, it was Ludwig…